Stay updated on ATB200 Safety & PK Clinical Trial
Sign up to get notified when there's something new on the ATB200 Safety & PK Clinical Trial page.

Latest updates to the ATB200 Safety & PK Clinical Trial page
- Check3 days agoChange DetectedAdded a new ahead-of-print citation with full author names and details; updated the page from v3.0.1 to v3.0.2, and removed the Back to Top element.SummaryDifference3%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check17 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with significant publications related to the study, including details about cipaglucosidase alfa and its efficacy in treating Pompe disease. Additionally, several outdated terms and categories have been removed.SummaryDifference11%
- Check24 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous status of no results posted.SummaryDifference0.2%
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to ATB200 Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATB200 Safety & PK Clinical Trial page.